Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| HERBALIFE LTD.HLF · Entity 4842 | Director | December 09, 2022 | December 13, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
HERBALIFE LTD.
Report date December 09, 2022 · Filed December 13, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 321,793 |
Reported balance
After 2022-12-09 transaction · row 1
1 source rowRow 1 · 2022-12-09 · Purchase · Acquired 7,800 · Balance 321,793 F1: This transaction was executed in multiple trades at prices ranging from $12.77 to $12.78. The price reported reflects the weighted average purchase price of $12.7768. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $12.77 to $12.78. The price reported reflects the weighted average purchase price of $12.7768. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 09, 2022 Filed Dec 13, 2022 21:34 UTC | HERBALIFE LTD. HLF · Entity 4842 | PurchaseCommon Stock | 7,800 | $12.78 | $99,659.04 |
DisclosureSEC source: 0001209191-22-060944 · doc4.xml · nonDerivative · entry 1 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,793 F1 · price: This transaction was executed in multiple trades at prices ranging from $12.77 to $12.78. The price reported reflects the weighted average purchase price of $12.7768. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 05, 2022 Filed May 9, 2022 20:29 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 5,387 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-027844 · doc4.xml · nonDerivative · entry 1 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,993 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2023, subject to continued service on the Issuer's Board of Directors through such date. Read SEC document |
| May 05, 2022 Filed Aug 4, 2022 00:38 UTC | HERBALIFE LTD. HLF · Entity 4842 | PurchaseCommon Stock | 5,000 | $25.27 | $126,325.00 |
DisclosureSEC source: 0001209191-22-044346 · doc4.xml · nonDerivative · entry 1 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 313,993 Read SEC document |
| May 24, 2021 Filed May 26, 2021 20:09 UTC | HERBALIFE LTD. HLF · Entity 4842 | SaleCommon Stock | 5,000 | $51.62 | $258,089.50 |
DisclosureSEC source: 0001209191-21-035908 · doc4.xml · nonDerivative · entry 1 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,606 F1 · price: This transaction was executed in multiple trades at prices ranging from $51.57 to $51.67. The price reported reflects the weighted average sale price of $51.6179. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 06, 2021 Filed May 10, 2021 23:42 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 2,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-031428 · doc4.xml · nonDerivative · entry 1 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 308,606 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2022, subject to continued service on the Issuer's Board of Directors through such date. Read SEC document |
| November 24, 2020 Filed Nov 25, 2020 00:15 UTC | HERBALIFE LTD. HLF · Entity 4842 | SaleCommon Stock | 1,573 | $48.35 | $76,054.55 |
DisclosureSEC source: 0001209191-20-060365 · doc4.xml · nonDerivative · entry 4 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,886 Read SEC document |
| November 23, 2020 Filed Nov 25, 2020 00:15 UTC | HERBALIFE LTD. HLF · Entity 4842 | SaleCommon Stock | 55,000 | $48.83 | $2,685,650.00 |
DisclosureSEC source: 0001209191-20-060365 · doc4.xml · nonDerivative · entry 3 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,459 F1 · price: This transaction was executed in multiple trades at prices ranging from $48.65 to $49.05. The price reported reflects the weighted average sale price of $48.83. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| November 20, 2020 Filed Nov 25, 2020 00:15 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Rights · Derivative | 9,052 | $0.00 Strike: $39.79 | $0.00 |
DisclosureSEC source: 0001209191-20-060365 · doc4.xml · derivative · entry 5 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,052 shares Expires 2020-12-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as covering 4,526 shares at an exercise price of $79.58 per share. F2 · shares: Adjusted to reflect the Issuer's May 14, 2018 2-for-1 stock split. The stock appreciation rights ("SARs") were previously reported as covering 4,526 shares at an exercise price of $79.58 per share. F3 · derivative.exercise_date: The SARs were granted on December 19, 2013. 50% vested on December 19, 2013, 25% vested on January 15, 2014 and the remaining 25% vested on April 15, 2014. Read SEC document |
| November 20, 2020 Filed Nov 25, 2020 00:15 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 7,479 | $48.16 | $360,188.64 |
DisclosureSEC source: 0001209191-20-060365 · doc4.xml · nonDerivative · entry 2 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 362,459 Read SEC document |
| November 20, 2020 Filed Nov 25, 2020 00:15 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 9,052 | $39.79 | $360,179.08 |
DisclosureSEC source: 0001209191-20-060365 · doc4.xml · nonDerivative · entry 1 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 369,938 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2020 Filed May 19, 2020 20:17 UTC | HERBALIFE LTD. HLF · Entity 4842 | SaleCommon Stock | 25,000 | $39.06 | $976,500.00 |
DisclosureSEC source: 0001209191-20-030458 · doc4.xml · nonDerivative · entry 1 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 360,886 F1 · price: This transaction was executed in multiple trades at prices ranging from $39.00 to $39.29. The price reported reflects the weighted average sale price of $39.06. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 11, 2020 Filed May 13, 2020 20:41 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 3,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-028843 · doc4.xml · nonDerivative · entry 1 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 385,886 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2021, subject to continued service on the Issuer's Board of Directors through such date. Read SEC document |
| May 23, 2019 Filed May 28, 2019 23:24 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Rights · Derivative | 15,006 | $0.00 Strike: $22.40 | $0.00 |
DisclosureSEC source: 0001209191-19-033103 · doc4.xml · derivative · entry 3 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 15,006 shares Expires 2019-05-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction represents an exercise and hold of stock appreciation rights ("SARS"). The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4. F2 · shares: These SARS were previously reported as covering 7,503 shares at an exercise price of $44.79 per share, and were adjusted to reflect the Issuer's May 14, 2018 stock split. Read SEC document |
| May 23, 2019 Filed May 28, 2019 23:24 UTC | HERBALIFE LTD. HLF · Entity 4842 | Tax withholdingCommon Stock | 7,776 | $43.22 | $336,078.72 |
DisclosureSEC source: 0001209191-19-033103 · doc4.xml · nonDerivative · entry 2 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 382,479 F1 · shares: The transaction represents an exercise and hold of stock appreciation rights ("SARS"). The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4. Read SEC document |
| May 23, 2019 Filed May 28, 2019 23:24 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 15,006 | $22.40 | $336,059.37 |
DisclosureSEC source: 0001209191-19-033103 · doc4.xml · nonDerivative · entry 1 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 390,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction represents an exercise and hold of stock appreciation rights ("SARS"). The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4. Read SEC document |
| May 06, 2019 Filed May 8, 2019 23:19 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 2,689 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-028353 · doc4.xml · nonDerivative · entry 1 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 375,249 F1 · shares: Consists of restricted stock units ("RSUs") granted under the Herbalife Ltd. 2014 Stock Incentive Plan. The RSUs will vest 100% on April 15, 2020, subject to continued service on the Issuer's Board of Directors through such date. F2 · balance_after: Amount reflected corrects the balance due to prior administrative error. Read SEC document |
| May 22, 2018 Filed May 24, 2018 20:11 UTC | HERBALIFE LTD. HLF · Entity 4842 | SaleCommon Stock | 20,000 | $53.78 | $1,075,600.00 |
DisclosureSEC source: 0001209191-18-032967 · doc4.xml · nonDerivative · entry 1 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 176,282 F1 · price: This transaction was executed in multiple trades at prices ranging from $53.70 to $53.81. The price reported reflects the weighted average sale price of $53.78. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 07, 2018 Filed May 9, 2018 21:15 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 1,195 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-028928 · doc4.xml · nonDerivative · entry 1 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,282 F1 · kind: Consists of restricted stock units ("RSU") under the Herbalife Nutrition Ltd. 2014 Stock Incentive Plan. Each RSU represents a contingent right to receive one share of Herbalife Nutrition Ltd. common stock on vesting. This award will vest 100% on April 15, 2019. Read SEC document |
| March 02, 2018 Filed Mar 2, 2018 23:40 UTC | HERBALIFE LTD. HLF · Entity 4842 | SaleCommon Stock | 2,297 | $92.10 | $211,553.70 |
DisclosureSEC source: 0001209191-18-015994 · doc4.xml · nonDerivative · entry 3 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,087 Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 23:40 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Rights · Derivative | 5,452 | $0.00 Strike: $53.29 | $0.00 |
DisclosureSEC source: 0001209191-18-015994 · doc4.xml · derivative · entry 4 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,452 shares Expires 2021-05-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reporting person received 2,297 shares of common stock upon the net exercise of the 5,452 stock appreciation rights ("SARs"). The reporting person forfeited 3,155 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 23:40 UTC | HERBALIFE LTD. HLF · Entity 4842 | Disposition to issuerCommon Stock | 3,155 | $92.10 | $290,575.50 |
DisclosureSEC source: 0001209191-18-015994 · doc4.xml · nonDerivative · entry 2 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 197,384 F1 · kind: The reporting person received 2,297 shares of common stock upon the net exercise of the 5,452 stock appreciation rights ("SARs"). The reporting person forfeited 3,155 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10. Read SEC document |
| February 28, 2018 Filed Mar 2, 2018 23:40 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 5,452 | $53.29 | $290,537.08 |
DisclosureSEC source: 0001209191-18-015994 · doc4.xml · nonDerivative · entry 1 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The reporting person received 2,297 shares of common stock upon the net exercise of the 5,452 stock appreciation rights ("SARs"). The reporting person forfeited 3,155 shares of common stock underlying SARs in payment of the exercise price using the closing stock price on February 28, 2018 of $92.10. Read SEC document |
| May 08, 2017 Filed May 10, 2017 00:41 UTC | HERBALIFE LTD. HLF · Entity 4842 | GrantCommon Stock | 1,665 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-031121 · doc4.xml · nonDerivative · entry 1 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,087 F1 · kind: Consists of restricted stock units under the Herbalife Ltd. 2014 Stock Incentive Plan. This award will vest 100% on April 15, 2018. Read SEC document |
| March 02, 2017 Filed Mar 2, 2017 22:30 UTC | HERBALIFE LTD. HLF · Entity 4842 | SaleCommon Stock | 2,758 | $56.48 | $155,771.84 |
DisclosureSEC source: 0001209191-17-016813 · doc4.xml · nonDerivative · entry 3 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 193,422 Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 22:30 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionStock Appreciation Rights · Derivative | 13,064 | $0.00 Strike: $22.94 | $0.00 |
DisclosureSEC source: 0001209191-17-016813 · doc4.xml · derivative · entry 4 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,064 shares Expires 2017-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 22:30 UTC | HERBALIFE LTD. HLF · Entity 4842 | Disposition to issuerCommon Stock | 5,306 | $56.49 | $299,735.94 |
DisclosureSEC source: 0001209191-17-016813 · doc4.xml · nonDerivative · entry 2 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,180 F1 · kind: The reporting person received 7,758 shares of common stock upon the net exercise of the 13,064 stock appreciation rights ("SARS"). The reporting person forfeited 5,306 shares of common stock underlying the SARS in payment of the exercise price, using the closing stock price on February 28, 2017 of $56.49 and sold 2,758 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise. Read SEC document |
| February 28, 2017 Filed Mar 2, 2017 22:30 UTC | HERBALIFE LTD. HLF · Entity 4842 | Exercise / conversionCommon Stock | 13,064 | $22.94 | $299,688.16 |
DisclosureSEC source: 0001209191-17-016813 · doc4.xml · nonDerivative · entry 1 Tartol John · CIK 0001343530 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.